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ABSTRACT 
Peptides have numerous advantages as the chains help treat cancer, tumor and several complex diseases. The review details on the different 
structures of peptides that can ensure actual and efficient delivery of therapy to tumor and cancer cases. The co-delivery system mainly aims to 
improve the therapeutic delivery process regarding manufacturing, targeting, and impact.  
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Introduction 
With the introduction of new drugs to improve the health 
status of patients, peptides are found to be better ingredients 
to enhance the overall drug delivery process1-5. Peptides are 
identified as amino acid monomer chains that can offer 
better effects on the patients. The first section of this review 
details about the assembly of peptides while the next part 
discusses more on the influence of peptide-based ligand on 
the health of the patient. Peptides quickly turn into proteins 
and can penetrate to the top layer of the patient’s skin 
thereby having a long-term impact of the medicine6-11. The 
final part of this report discusses how peptides can serve as 
better drug delivery mechanism leaving a significant 
development in the health aspect of the person.  
Assembly of Peptides 
Self-assembly is a particular feature of peptides. In this case, 
self-assembly enables the development of nanoscale 
structures comprising of nucleotides, amino acids or 
phospholipids12-14. This assembly can manage the non-
covalent interaction between attractive and repulsive forces. 
In the field of material science, nanostructure made of 
hydrogel has an excessive capacity to retain the water 
content and build rigid structures. It is observed that 
peptide-based hydrogel is effective in maintaining the 
intermolecular interaction and enabling the biocompatibility 
between the bonds15-18.  
The other advantage with the peptide comprising of the 
hydrogel is the formation of nanofibers and crosslinks even 
in the aqueous media. This structure is already found to be 
useful in the field of in vitro cell imaging research19-22. 
Further, this form of peptide delivery is found to enable 
better blood circulation thereby curing tumor and arthritis. 
Drug delivery is a critical process where it can have 
numerous side effects if the amino acids react differently. 
When self-assembled peptide combined with the hydrogel is 
introduced, it can have antifungal, antibiotic, anticoagulation 
and anti-inflammatory properties. This is also photostable, 
and this structure of peptide can have a great future in the 
biomedical field.   
Peptide-based ligand 
In the medical field, the targeted ligand includes peptides, 
proteins, and antibodies. For better therapeutic delivery, 
ligands comprising of liposomes have better consistency 
regarding purity and binding affinity23-29. RGD peptide, 
which is a combination of arginine, glycine and aspartic 
acids, takes the responsibility to anchor the cells. To treat the 
tumor cases, doxorubicin (DOX) is widely used. This RGD 
peptide is known to increase the delivery of doxorubicin 
with stabilized cells and activated performance of the drug.  
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The advantage with RGD peptide is its flexibility in the 
structures. While the natural structure is advantageous, the 
mimetic version of RGD can improve stability and affinity. 
The other famous structure of RGD is cyclic which targets the 
ligands and binds its relationship with integrin30-33. In the 
field of biomedicine, many biologists face difficulties in the 
penetration of internal cells and this is feasible with the cell 
penetrating peptide in place. This has a high affinity, and its 
impact is much visible in treating cancer cases.  
Usually, the cancer cells are difficult to target, and the dual 
ligand enables the target on cancer cells and the transfer 
time is quick. Liposomes have been regarded as an effective 
drug delivery system34-36. The problem with the present 
system is the inability to target the active ligands. With the 
use of DOX, there is undoubtedly a need to activate the active 
ligands so peptides can work on binding the tissues and 
cancer cells and enrich the efficiency of the overall process. 
The peptide ligand assures to offer a long-term impact in 
usage for a shorter period.  
Peptide-based drug delivery 
The recent treatments available for cancer have had 
problems in the activation of cancer cells and targeting. 
Nanotechnology has proved to be a better method to treat 
the cancer patients and reduce the toxicity of the chemicals 
used7,23. Amphiphilic dendrimer including hydrophilic 
dendritic shell tends to promise a better drug delivery 
system due to the ease in preparation and high 
biocompatibility. With the introduction of this acid promoted 
drug, it is possible to improve the efficiency of 5-Fu/Dox-
DNM in the patient's body.  
The process of preparation of 5-Fu/Dox-loaded micelles 
follows ultrasonication dialysis method. This is highly 
suitable to treat cases requiring dialysis and also cancer. 
Both Dox and 5-Fu will have to be loaded into micelles, and 
they improve hydrogen bond and electrostatic interactions. 
The co-delivery of 5-Fu and Dox is found to reduce the 
duration of tumor in the body and also minimize cancer-
causing agents37,38. The enhanced process of drug release is 
found to target the affected cells and induce the toxics that 
can help achieve a reduced cancer effect.  
Peptides can replace the traditional chemotherapeutic drugs 
with a powerful method to target and eliminate the presence 
of cancer. This also improves the resistance of the affected 
patient and turns dormant cells invisible. Peptide treatment 
with the co-delivery of 5-Fu and Dox can promise a better 
choice of cancer therapy30,32.  
 
Conclusion 
Peptides are known to be a chain of amino acids that have 
antioxidant and antifungal properties and help coagulate 
between the cells. In recent time, the rate of patients affected 
with cancer is increasing for which co-delivery or peptide 
ligands can be of greater use. The advantage with this 
therapeutic system is the improved resistance and stability 
on the targeted bodies. It can help in targeting the specific 
cells, and the cost of manufacturing is less. This is found to be 
the future of biomedicine to treat cancer cases.  
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